Nimesulide Alter (Nimesulide)

Nimesulide works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins that mediate pain, fever and inflammation. This selective action aims to preserve COX‑1 activity, helping to limit gastrointestinal side effects while delivering anti‑inflammatory benefits.

The appropriate dose of Nimesulide Alter is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Nimesulide Alter in pregnancy and lactation has not been established. It is generally avoided in pregnant or nursing women unless the potential benefit outweighs the risk, and only under direct medical supervision.

To order Nimesulide Alter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nimesulide offers selective COX‑2 inhibition, which may reduce gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or diclofenac. However, its safety profile still requires monitoring for liver and renal effects, and choice of therapy should be individualized by the prescriber.

Nimesulide Alter should be stored at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Nimesulide Alter is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may help minimise gastrointestinal discomfort. The exact timing and frequency are set by the prescribing clinician.

Serious risks include severe liver injury, life‑threatening skin reactions such as Stevens‑Johnson syndrome, gastrointestinal bleeding or ulceration, and acute renal failure. Patients should be instructed to seek immediate medical attention if they notice jaundice, rash, unexplained bleeding or sudden kidney problems.

Nimesulide Alter should be avoided in individuals with known hypersensitivity to nimesulide or other NSAIDs, active peptic ulcer disease, severe liver or kidney impairment, uncontrolled hypertension, and in patients taking anticoagulants without close monitoring.